Core Laboratories CLB Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $22.7M+18.5% | $19.16M+26.7% | $15.12M-2.0% | $15.43M— | ||
| $454.73M-1.2% | $460.09M+41.9% | $324.25M— | —— | ||
| $231.54M-12.8% | $265.5M+17.8% | $225.32M— | —— | ||
| $40.61M+3.3% | $39.32M+16.4% | $33.77M— | —— | ||
| $7.27M-29.5% | $10.32M-24.8% | $13.72M+67.5% | $8.19M— | ||
| $214.67M-3.0% | $221.33M-0.8% | $223.14M+5.4% | $211.7M— | ||
| $99.45M+2.5% | $97.06M-2.6% | $99.63M-5.1% | $105.03M-5.3% | ||
| $54.35M-3.8% | $56.49M+4.9% | $53.84M+2.8% | $52.38M— | ||
| $105.79M+6.4% | $99.45M0.0% | $99.45M0.0% | $99.45M— | ||
| $7.12M+11.2% | $6.4M-7.6% | $6.93M-7.4% | $7.48M— | ||
| $39.48M-18.5% | $48.45M+35.5% | $35.77M— | —— | ||
| $35.26M+1.4% | $34.79M+1.7% | $34.22M+1.4% | $33.75M— | ||
| $584.01M-0.2% | $585.13M-0.2% | $586.4M+1.4% | $578.35M-0.4% | ||
| $154.42M+12.3% | $137.53M+38.0% | $99.67M— | —— | ||
| $26.53M+15.8% | $22.9M+21.9% | $18.79M-19.8% | $23.43M— | ||
| $11.46M+7.2% | $10.69M+5.1% | $10.18M-13.0% | $11.7M— | ||
| $4.26M-56.2% | $9.71M+33.4% | $7.28M+140% | $3.03M— | ||
| $106.02M+3.5% | $102.45M+16.3% | $88.1M-14.6% | $103.14M— | ||
| $110.26M-12.6% | $126.11M-22.7% | $163.13M-5.4% | $172.39M— | ||
| $42.31M-2.4% | $43.34M+3.0% | $42.08M+9.8% | $38.31M— | ||
| $0— | $0— | $0— | —— | ||
| $53.77M-0.5% | $54.03M+3.4% | $52.25M— | —— | ||
| $0— | $0— | $0— | —— | ||
| $15.85M-23.6% | $20.73M+3.5% | $20.04M-4.0% | $20.88M— | ||
| $0— | $0— | $0— | $0— | ||
| $470K0.0% | $470K+0.2% | $469K-60.7% | $1.19M— | ||
| $110.25M+0.6% | $109.55M-0.4% | $110.01M+7.6% | $102.25M— | ||
| $172.66M+19.2% | $144.86M+20.0% | $120.76M+40.5% | $85.95M— | ||
| -$5.81M-0.6% | -$5.77M-16.0% | -$4.97M-31.6% | -$3.78M— | ||
| $11.59M+357% | $2.54M+75.1% | $1.45M+6.4% | $1.36M— | ||
| $6.22M+8.3% | $5.75M+15.1% | $4.99M+6.3% | $4.7M— | ||
| $265.99M+7.9% | $246.57M+9.7% | $224.82M+22.0% | $184.26M— | ||
| $584.01M-0.2% | $585.13M-0.2% | $586.4M+1.4% | $578.35M— | ||
| $6.94M-34.1% | $10.52M+106% | $5.09M+0.6% | $5.06M— | ||
| $35.26M+1.4% | $34.79M+1.7% | $34.22M+1.4% | $33.75M— | ||
| $54.35M-3.8% | $56.49M+4.9% | $53.84M+2.8% | $52.38M— | ||
| $67.38M-3.2% | $69.61M+0.6% | $69.2M+0.9% | $68.57M— | ||
| $7.12M+11.2% | $6.4M-7.6% | $6.93M-7.4% | $7.48M— | ||
| $54.35M-3.8% | $56.49M+4.9% | $53.84M+2.8% | $52.38M— | ||
| $35.26M+1.4% | $34.79M+1.7% | $34.22M+1.4% | $33.75M— | ||
| $54.35M-3.8% | $56.49M+4.9% | $53.84M+2.8% | $52.38M— | ||
| $35.26M+1.4% | $34.79M+1.7% | $34.22M+1.4% | $33.75M— | ||
| $26.53M+15.8% | $22.9M+21.9% | $18.79M-19.8% | $23.43M— | ||
| $5.55M-40.5% | $9.33M+96.3% | $4.76M-20.0% | $5.94M— | ||
| $26.53M+15.8% | $22.9M+21.9% | $18.79M-19.8% | $23.43M— | ||
| $4.27M-39.9% | $7.11M+19.6% | $5.94M+23.2% | $4.82M— | ||
| $29.38M-5.6% | $31.12M+1.9% | $30.54M-4.0% | $31.81M— | ||
| $110.26M-12.6% | $126.11M-22.7% | $163.13M-5.4% | $172.39M— | ||
| $164.02M-9.0% | $180.14M-16.4% | $215.39M-3.1% | $222.39M— | ||
| $110.25M+0.6% | $109.55M-0.4% | $110.01M+7.6% | $102.25M— | ||
| $470K0.0% | $470K+0.2% | $469K-60.7% | $1.19M— | ||
| $0— | $0— | $0— | $0— | ||
| $11.59M+357% | $2.54M+75.1% | $1.45M+6.4% | $1.36M— | ||
| $29.38M-5.6% | $31.12M+1.9% | $30.54M-4.0% | $31.81M— | ||
| $8M-11.8% | $9.07M-28.6% | $12.7M-44.5% | $22.88M— | ||
| $7.27M-29.5% | $10.32M-24.8% | $13.72M+67.5% | $8.19M— | ||
| $110.26M-12.6% | $126.11M-22.7% | $163.13M-5.4% | $172.39M— | ||
| $6.22M+8.3% | $5.75M+15.1% | $4.99M+6.3% | $4.7M— | ||
| $16.68M+104% | $8.16M+6.6% | $7.65M-8.5% | $8.36M— | ||
| $9.73M-4.3% | $10.18M+24.8% | $8.15M-48.0% | $15.67M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Core Laboratories's total assets?
- Core Laboratories (CLB) holds $587.7M in total assets, up 0.3% year over year.
- How much debt does Core Laboratories have?
- Core Laboratories carries $167.8M in total debt against $268.9M of shareholders' equity, a debt-to-equity ratio of 0.62.
- How much cash does Core Laboratories have?
- Core Laboratories holds $22.8M in cash and equivalents.
- Can Core Laboratories cover its short-term obligations?
- Its current ratio is 2.05 — current assets exceed current liabilities.
- Where does Core Laboratories's balance sheet data come from?
- Every line is extracted from Core Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
